UAE Leaders Meet in Dubai to Advance National Development Agenda

UAE national development takes center stage: UAE...

UAE and France Express Solidarity with Kuwait After Recent Attacks

Kuwait-UAE diplomatic engagement strengthens regional security: Following...

Kuwait Banks Ensure Uninterrupted Services with 24/7 Payment Systems

Kuwait’s banking sector continues to provide uninterrupted...
HomeLifestyleHMC Research Team...

HMC Research Team Wins Prestigious Hamdan Medical Award

The Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences has announced the winners of the 2024 Hamdan Medical Awards. These awards honor excellence in medical research and innovation across the Arab world and the UAE. Among the distinguished recipients, a research team from Hamad Medical Corporation (HMC) received the prestigious Arab Award for Research in Healthcare. They were recognized for their groundbreaking study on transitioning to oral antibiotics in Gram-negative bacteremia cases.

The clinical trial, conducted by HMC’s infectious disease specialists in collaboration with Kuwait University and Istanbul Medipol University, explored the safety and effectiveness of shifting from intravenous (IV) to oral antimicrobial therapy. The study focused on patients with Enterobacterales bacteremia who had completed 3-5 days of microbiologically active IV therapy.

The research provides valuable insights into antimicrobial stewardship and aims to enhance patient care by optimizing antibiotic use. Dr. Muna Al Maslamani, Medical Director of HMC’s Communicable Disease Center and Hamad General Hospital, expressed pride in the team’s achievement. She emphasized the collaborative effort behind the study.

“This award is a testament to our team’s dedication and highlights the significance of joint research in improving patient care. Our study demonstrates the potential for better clinical outcomes through the thoughtful use of antibiotics. I extend my deepest gratitude to all the researchers, clinicians, and collaborators involved,” Dr. Al Maslamani stated.

The award-winning team includes Dr. Ali Omrani, Dr. Yasser El Deeb, Dr. Mossad Al Sammawi, Dr. Adila Shwakat, Dr. Fatma Bin Abid, Dr. Suliman Abu Jarir, Dr. Ahmed Zaqout, Dr. Shahad Shaar, Dr. Mohamed Salem Al Gara, Dr. Khalid M. Shunnar, Dr. Mohammad Elmabrok, and Dr. Mohamed Islam Alghazzawi.

The Hamdan Medical Awards celebrate exceptional contributions to healthcare. Categories include the Arab Award for Research in Healthcare, the Arab Award in Genetics, the Best Research in Healthcare Award, and the Innovation in Healthcare Award. The recognition of HMC’s team underscores Qatar’s growing influence in global medical research and commitment to advancing healthcare practices.

Submit Your Article

Share your story with Khaleej Telegraph readers

Minimum 300 words recommended

Our editorial team will review your submission within 48 hours

Continue reading

Last Chance to Visit Mathaf Spring 2025 Exhibitions Before August 9 Closure

Arab Museum of Modern Art urges art lovers to visit its ongoing Mathaf Spring 2025 exhibitions. These exhibitions will close on August 9. They are part of the Qatar Creates Spring/Summer 2025 season and offer a rare opportunity. Art lovers can explore Qatari...

Israeli Sovereignty Over West Bank Condemned by Qatar, Allies, and International Groups

The State of Qatar, along with nine nations, the Arab League, and the Organization of Islamic Cooperation (OIC), has strongly condemned the Israeli Knesset’s recent decision to extend "Israeli sovereignty over West Bank." This move, according to the joint statement,...

Portfolio Decarbonisation Strategy by Msheireb Properties Sets New Sustainability Benchmark

Msheireb Properties has officially launched a groundbreaking portfolio decarbonisation strategy in partnership with global consultancy Cundall. Notably, this ambitious initiative targets the developer’s entire real estate portfolio in Msheireb Downtown Doha. Importantly, this project is the first of its kind at this...